Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02138422 |
|---|---|
| Brief Title: | A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal Cancer |
| First Submitted : | May 12, 2014 |
| First Submitted that Met QC Criteria : | May 13, 2014 |
| First Posted : | May 14, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | February 25, 2021 |
| Last Update Posted : | March 1, 2021 |